Form 4 for IBRX ImmunityBio, Inc.
Accepted 2025-01-24 00:00:00 ET · period of report 2025-01-22 · accession 0001326110-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-24 | 2025-01-22 | IBRX | Simon Barry J. | Dir | M - OptEx | $2.00 | +110.0K | 3.23M | +4% | +$220.0K |
| D | 2025-01-24 | 2025-01-22 | IBRX | Simon Barry J. | Dir | M - OptEx | $0.00 | -110.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-22 | M | A | 110,020 | $2.00 | 3,233,781 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-01-22 | M | D | 110,020 | $0.00 | 0 | D | $2.00 · — to 2025-02-16 | 110,020 Common Stock | (F2) Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option was January 16, 2015. |